XOVR ERShares Private-Public Crossover ETF

Expense Ratio
1.81%
Previous close
$17.00
Est. 12 months change
+39.77%
Projected Price
$23.76

Profitability Metrics

Return on Equity (ROE)
7.84%
Return on Assets (ROA)
4.64%
Return on Invested Capital (ROIC)
30.78%
Weighted Average Cost of Capital (WACC)
20.34%
ROIC - WACC
10.44%
Updated : 2026-04-03 19:02 ET

Valuation Metrics

P/E Ratio
35.87
Forward P/E
25.21
PEG Ratio
1.38
Debt Current Ratio
2.58

Growth & Cash Flow

Gross Margin
58.39%
Operating Margin
-122.32%
FCF Margin
39.83%
TTM Revenue Growth
-10.60%
Projected 12M EPS Growth
42.30%

Price Change

Price % from 50 SMA
-3.68%
Price % from 200 SMA
-12.78%
6 Months
-19.66%
1 Year
3.85%
2 Years
11.00%
The above metrics represent weighted averages, calculated using each stock's individual value weighted by its proportion of ETF holdings.

Top 10 Holdings

Stock TickerWeight
NA49.12%
NVDA3.97%
META3.24%
UI2.69%
ANET2.54%
PLTR2.47%
IBKR2.30%
GOOGL1.85%
TSLA1.84%
RMD1.81%

ETF Analysis

Fund Overview

ERShares Private-Public Crossover ETF (XOVR) currently reports 31 stock positions (subject to change), placing it in the diversified without being diffuse range by holdings breadth. The top line-up is NA (49.12%), NVDA (3.97%), META (3.24%), with NA as the largest single weight at 49.12%. Together, the top three holdings account for 56.33%, which represents a dominant share and increases sensitivity to the performance of a narrow leadership group. Taken together, the portfolio's structure reflects a deliberate trade-off between conviction at the top and risk spreading across the broader holding set.

Profitability & Capital Efficiency

On a capital return basis, ROIC is 30.78%, WACC is 20.34%, and the economic spread is 10.44%. On balance, ROIC clears WACC by a meaningful margin, suggesting the portfolio's holdings are creating rather than consuming intrinsic value. Supporting metrics show ROE at 7.84% and ROA at 4.64%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.

Valuation

On an earnings multiple basis, trailing P/E of 35.87, forward P/E of 25.21, PEG of 1.38. Forward P/E sits materially below trailing P/E, which supports the view that earnings expectations are improving and the basket looks cheaper on forward numbers. At this PEG level, growth-adjusted valuation looks attractive — the market appears to be paying a reasonable price for the earnings growth embedded in estimates. A current ratio of 2.58 across the holding set reflects strong short-term liquidity. Combining multiples and liquidity, the portfolio appears adequately priced for its current earnings trajectory, with balance sheet health providing a degree of downside resilience.

Margins & Cash Generation

Stripping to unit economics, gross margin sits at 58.39%, operating margin at -122.32%, and free cash flow margin at 39.83%. Gross margins are healthy, suggesting solid pricing power across the underlying holdings. At this operating margin level, businesses are generating little to no earnings after overhead — a sign of early-stage or high-investment dynamics. The portfolio's free cash flow margin is exceptional, pointing to capital-light businesses with strong reinvestment optionality. Across the three margin layers, the picture is inconsistent — a reminder that aggregate metrics can mask meaningful variation at the individual holding level.

Growth & Forward Outlook

Connecting operational trends with market expectations, TTM revenue growth of -10.60% signaling contraction in aggregate revenues across the portfolio, while the estimated 12-month price change of 40.17%, where consensus targets imply substantial appreciation potential over the next 12 months. At 42.3%, the projected 12-month EPS growth rate is strong enough to be a primary driver of the forward investment case rather than a peripheral supporting detail. Operating momentum and analyst expectations are related but distinct — the former is backward-looking by nature, the latter inherently speculative. Against that backdrop, the more durable question is whether operating trends can be sustained long enough for analyst expectations to be validated. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Buy

Overall, the fundamentals support a constructive stance — execution remains the key driver of whether the forward case is fully validated.

The views expressed above are derived from quantitative data only and should not be relied upon as financial advice. Investment decisions should be based on your own research and risk tolerance.